Fig. 9From: N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1A schematic model of circSLCO1B3 function in tumor proliferation, metastasis and immunosuppression.Back to article page